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Summary
 
Itk is a member of the Btk/Tec/Itk family of nonreceptor protein tyrosine kinases (PTKs), and
has been implicated in T cell antigen receptor (TCR) signal transduction. Lck and Fyn are the
Src-family nonreceptor PTKs that are involved in TCR signaling. To address the question of
how these members of different families of PTKs functionally contribute to T cell development
and to T cell activation, mice deficient for both Itk and either Lck or Fyn were generated. The
Itk/Lck doubly deficient mice exhibited a phenotype similar to that of Lck-deficient mice. The
phenotype of the Itk/Fyn doubly deficient mice was similar to that of Itk deficient mice. How-
ever the Itk/Fyn doubly deficient mice exhibited a more severe defect in TCR-induced prolif-
eration of thymocytes and peripheral T cells than did mice deficient in either kinase alone.
These data support the notion that Itk and Fyn both make independent contributions to TCR-
induced T cell activation.
 
M
 
ultiple nonreceptor protein tyrosine kinases (PTKs)
are activated after TCR stimulation. These PTKs are
responsible for the tyrosine phosphorylation of the TCR-
 
z
 
and CD3 chains, the kinases themselves, and a number of
cellular substrates (1, 2). Among these cytoplasmic PTKs
are the Src-family members such as Fyn and Lck, and the
ZAP-70 and Syk kinases. Functionally important interac-
tions as well as physical interactions between these two
families of PTKs have been well studied (for review see ref-
erence 3).
Recently, a new family of nonreceptor PTKs, expressed
specifically in the hematopoietic system (4), has been impli-
cated in antigen receptor–mediated responses. Members of
this family include Btk, Itk, and Tec. Itk is highly expressed
in T cells and mast cells. Mice deficient in Itk expression
have a reduced number of mature T cells, which also are
compromised in proliferation after TCR stimulation (5).
Thus, this third class of nonreceptor PTKs, in addition to
those of the Src and Syk/ZAP-70 families, is involved in T
cell development and activation.
The mechanism by which Itk is regulated in T cells is
not known. Activation of Btk by Src family PTKs has been
observed (6, 7). This observation raises the possibility that
an Src family kinase might interact functionally with Itk in
T cells. Thymic development and T cell functional re-
sponses in mice deficient in Lck or Fyn do not mimic the
defects observed in Itk-deficient mice. Lck-deficient mice
exhibit a prominent but incomplete developmental arrest at
the transition from the CD4
 
2
 
CD8
 
2
 
 (double negative, DN)
to the CD4
 
1
 
CD8
 
1
 
 (double positive, DP) stage of develop-
ment. The few peripheral T cells that do develop have
markedly impaired TCR functional responses (8). In mice
lacking Fyn, thymic development occurs normally, but
markedly reduced thymocyte proliferation and some dimi-
nution in peripheral T cell proliferation in response to TCR
stimulation were observed (9, 10). A complete arrest in the
transition of the DN cells to DP cells in mice deficient in
both Lck and Fyn has been observed (11, 12). These studies
suggest that Lck and Fyn have some redundant roles in
TCR signal transduction. To address whether Itk and the
Src family members expressed in T cells have overlapping
or nonoverlapping functions in T cell development and ac-
tivation, we generated mice deficient in both Itk and Fyn,
as well as mice deficient in both Itk and Lck. This study
provides evidence that Fyn and Itk both make important
independent contributions to the functional responses of thy-
mocytes and T cells.
 
Materials and Methods
 
Generation of Itk/Fyn and Itk/Lck Doubly Deficient Mice.
 
Itk-
deficient mice have been previously reported (5). Fyn-deficient
mice were obtained from Paul L. Stein and Philippe Soriano (10)
at Fred Hutchinson Cancer Research Center (Seattle, WA). Lck-
deficient mice were obtained from Tak W. Mak (Amgen Insti-
tute, Toronto, Canada; reference 8). Itk/Fyn and Itk/Lck doubly
deficient mice were obtained by breeding Itk-deficient mice with
Fyn-deficient mice and Lck-deficient mice, respectively. Geno-
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typing of these mice was carried out using PCR. The oligonucle-
otides for genotyping the 
 
itk
 
 locus are as follows: Itk knockout
(KO): ASneo
 
1
 
, 5
 
9
 
 ATTGAACAAGATGGATTGCAC 3
 
9
 
; ASneo
 
2
 
,
5
 
9
 
 CGTCCAGATCATCCTGATC 3
 
9
 
; Itk WT: itk420, 5
 
9
 
 TGG-
GTGCTGACCCTTAAAGAAG 3
 
9
 
; itkintron3a, 5
 
9
 
 GCCGTA-
AATGAACAGGTGGTGA 3
 
9
 
. The expected size of Itk KO is
475 bp, and that of Itk WT is 218 bp. The ASneo
 
1
 
 and ASneo
 
2
 
primers are located in the 
 
neo
 
 gene, and thus will also amplify
from the 
 
neo
 
 insertions of the Fyn-deficient mice and Lck-defi-
cient mice. Additional PCR reactions using the 
 
itk
 
 KO-specific
oligoes were performed to distinguish 
 
itk
 
1
 
/
 
1
 
 and 
 
itk
 
1
 
/
 
2
 
 in certain
genotype combinations (5).
The oligonucleotides for genotyping the 
 
fyn
 
 locus are as follows:
Fyn KO: neo3
 
9
 
, 5
 
9
 
 GCATCGCCTTCTATCGCCTTCTTG-
ACG 3
 
9
 
; fynR, 5
 
9
 
 GCAAAACAACCCACACAGAG 3
 
9
 
; Fyn WT:
fynF, 5
 
9
 
 TTACCCTCTGAGCATCTGAC 3
 
9
 
; fynR, see above.
The expected size of Fyn KO is 
 
z
 
400 bp, and that of Fyn WT is
 
z
 
550 bp. The oligonucleotides for genotyping the 
 
lck
 
 locus are as
follows: Lck KO: neo.lck, 5
 
9
 
 TATCAGGACATAGCGTTGGC-
TACCC 3
 
9
 
; lckR, 5
 
9
 
 CTTAGACTCACGTGCTCCACAGGTA
3
 
9
 
; Lck WT: lckF, 5
 
9
 
 TGGTGAGACCTGACAACTGTCCGGA
3
 
9
 
; lckR, see above. The expected size of Lck KO is 560 bp, and that
of Lck WT is 375 bp. Each PCR reaction was carried out indi-
vidually under similar conditions. The typical conditions are 93
 
8
 
C
for 30 min for denaturation, 55
 
8
 
C for 45 min for annealing, and
74
 
8
 
C for 45 min for amplification, with a total of 35 cycles of the
above three steps, followed by a 74
 
8
 
C for 3-h step to finish up the
reaction.
 
Flow Cytometric Analysis.
 
Flow cytometry was performed by
staining 10
 
6
 
 freshly isolated thymocytes and lymph node cells in
100 
 
m
 
l of PBS supplemented with 0.3% BSA and 0.01% sodium
azide on ice for 30 min. For three-color analysis, cells were first
 
stained with various biotin-conjugated antibodies against different
lymphocyte surface proteins, followed by staining with a cocktail
of streptavidin-TRICOLOR (Caltag Labs, San Francisco, CA),
CD4-PE (YTS191.1; Caltag), and CD8-FITC (CT-CD8
 
a
 
, Cal-
tag). Cells were analyzed on a FACScan
 
Ò
 
 or FACSCalibur using
the Lysis II or the CellQuest softwares. Viable cells were gated on
the basis of forward- and side-light scattering. Additional anti-
bodies used included anti-CD69 (H1.2F3), anti-heat stable anti-
gen (M1/69), anti-TCR
 
ab
 
 (H57-597), and anti-IgM (R6-60.2),
all from PharMingen (San Diego, CA).
 
Cell Proliferation Assays.
 
Complete medium (RPMI 1640
supplemented with 10% FCS, 2 mM 
 
l
 
-glutamine, 50 
 
m
 
M 
 
b
 
-mer-
captoethanol, 100 
 
m
 
M nonessential amino acids, 50 U/ml penicil-
lin, and 50 
 
m
 
g/ml streptomycin) was used for cell culture and
preparation. Responder cells were isolated from thymi or spleens of
age-matched wild-type, 
 
itk
 
1
 
/
 
2
 
fyn
 
1
 
/
 
1
 
, 
 
itk
 
1
 
/
 
2
 
fyn
 
2
 
/
 
2
 
,
 
itk
 
2
 
/
 
2
 
fyn
 
1
 
/
 
1
 
,
and 
 
itk
 
2
 
/
 
2
 
fyn
 
2
 
/
 
2
 
 mice (8–10-wk old, H-2
 
b/b
 
). Splenocytes from
BALB/c (H-2
 
d/d
 
) and C57BL/6 (H-2
 
b/b
 
) were inactivated by ir-
radiation (
 
z
 
2,000 rad). Proliferation assays were set up in a vol-
ume of 200 
 
m
 
l in flat-bottomed wells of microtiter plates. For the
MLR, serial dilutions of 4 
 
3
 
 10
 
5
 
, 2 
 
3
 
 10
 
5
 
, 1 
 
3
 
 10
 
5
 
, and 0.5 
 
3
 
10
 
5
 
 splenocytes were mixed with 5 
 
3
 
 10
 
5
 
 stimulator cells of vari-
ous types in each well, and were incubated for 96 h before pulsing
for 16 h with 1 
 
m
 
Ci of [
 
3
 
H]thymidine per well. For other cell
proliferation assays, 5 
 
3
 
 10
 
4
 
 cells were mixed with 5 
 
3
 
 10
 
5
 
 irradi-
ated C57BL/6 splenocytes plus anti-CD3 (purified 145-2C11 at
1.5, 0.5, 0.167, and 0.056 
 
m
 
g/ml final concentration) in the pres-
ence of PMA (1 ng/ml). Cells were incubated for 48 h before
pulsing for 16 h with 1 
 
m
 
Ci of [
 
3
 
H]thymidine per well. Cellular
radioactivity was harvested using a microtiter plate cell harvester
(Tomtec, Orange, CT). All assays were done in triplicates, and
the mean and standard deviation are presented.
 
Table 1.
 
T Cell Populations in the Thymus and Lymph Nodes of 
 
1
 
/
 
1
 
, fyn
 
2
 
/
 
2
 
, itk
 
2
 
/
 
2
 
, and fyn
 
2
 
/
 
2
 
itk
 
2
 
/
 
2
 
 Mice
 
Genotype Source Total cells
Percentage 
T cells
 
§
 
Total 
T cells
 
§
 
Percentage of total cells
CD4/CD8
ratio CD42CD82 CD41CD81 CD41CD82 CD42CD81
1027 1027
1/1 (n 5 12)* Thymus 10.2 6 4.3 2.1 6 0.8 85.7 6 4.5 9.0 6 3.5 3.2 6 1.3 3.0 6 1.0
fyn2/2 (n 5 3)* Thymus 17.2 6 3.3 2.0 6 1.2 88.6 6 1.9 6.9 6 2.6 2.6 6 0.3 2.6 6 0.7
itk2/2 (n 5 16)* Thymus 8.7 6 1.8 3.2 6 1.2 80.7 6 8.0 7.1 6 2.6 8.9 6 6.2 1.0 6 0.5
fyn2/2itk2/2 
(n 5 7)*
Thymus 12.3 6 4.2 3.7 6 1.5 84.7 6 4.5 6.7 6 2.8 5.0 6 1.5 1.4 6 0.5
1/1 (n 5 12)* Lymph 
nodes‡
6.1 6 1.4 77.8 6 8.0 4.7 6 1.1 3.3 6 1.5 1.2 6 0.9 47.4 6 9.2 26.0 6 2.4 1.8 6 0.4
fyn2/2 (n 5 3)* Lymph 
nodes‡
6.6 6 1.6 74.8 6 6.9 5.0 6 1.6 1.9 6 1.0 1.4 6 1.9 47.0 6 4.7 24.4 6 3.0 2.0 6 0.3
itk2/2 (n 5 16)* Lymph 
nodes‡
6.1 6 2.3 60.7 6 9.2 3.6 6 1.4 5.2 6 2.3 1.1 6 1.9 27.2 6 5.5 27.2 6 7.9 1.2 6 0.7
fyn2/2itk2/2 
(n 5 7)*
Lymph 
nodes‡
5.9 6 2.0 54.8 6 7.6 3.2 6 1.0  5.8 6 3.7 0.7 6 0.4 25.7 6 3.2 22.6 6 5.1 1.2 6 0.4
Data are expressed as mean 6 standard deviation.
*Mice, 7–12 wk old; numbers of animals studied are shown in parentheses.
‡Cervical, brachial, axillary, superficial inguinal, and mesenteric.
§The number of T cells in the lymph nodes was calculated based on the percentages of cells staining positive with anti-CD3e.2071 Liao et al. Brief Definitive Report
Results
T Cell Development in the Absence of Both Itk and Fyn.
Maturation of thymocytes takes place in an ordered se-
quence of developmental events (13). Early immature thy-
mocytes do not express either the CD4 or the CD8 core-
ceptors (DN). As a result of pre-TCR signaling events, the
DN cells acquire expression of both CD4 and CD8 to be-
come DP cells. Subsequently, expression of one of the co-
receptors is extinguished, and the thymocytes become ma-
ture CD41 and CD81 single positive T cells. Mice lacking
Fyn, an Src family nonreceptor PTK have normal numbers
of thymocyte and T cell subpopulations as well as normal
levels of surface expression of the TCR chains (Table 1 and
Fig. 1), consistent with previous reports (9, 10). On the
other hand, mice deficient in Itk have a partial block in T
cell development (Table 1 and Fig. 1) in agreement with
our previous studies (5). Itk-deficient mice have reduced
numbers of mature lymph node T cells as well as a reduced
ratio of CD4 to CD8 single positive cells in the thymus and
the periphery.
To address whether Itk and Fyn might functionally in-
teract, we examined the developmental consequences of a
defect in both of these kinases. Mice deficient for both Fyn
and Itk expression were derived by breeding. Analysis of the
Itk/Fyn doubly deficient mice demonstrated similar thymic
and peripheral T cell phenotypes as the Itk-deficient mice
(Table 1 and Fig. 1). Hence, the absence of Fyn did not fur-
ther enhance the developmental consequences of Itk-defi-
ciency.
A few mice deficient in both Lck and Itk were also ob-
tained. The developmental consequences of this breeding
revealed that mice deficient in both Itk and Lck had thymic
phenotypes indistinguishable from Lck-deficient mice (data
not shown). A partial developmental arrest at the DN to
DP transition and a 10-fold reduction in thymocyte number
were observed, consistent with studies of the Lck-deficient
mice previously reported (8). As observed in the Lck-defi-
cient mice, only a few peripheral T cells were detectable in
the spleens and lymph nodes of the Itk/Lck doubly defi-
cient animals. Thus, the absence of Itk does not further
augment the already severe phenotype observed in the Lck
deficient mice.
Thymocyte Proliferation in the Absence of Both Itk and
Fyn. To address whether Itk and Fyn make independent
contributions to the processes that lead to T cell activation,
thymocytes and splenocytes were prepared from Itk/Fyn
doubly deficient mice and compared with those from mice
lacking either kinase alone in TCR-mediated proliferative
responses. Thymocytes lacking either Fyn or Itk consis-
tently showed a reduction in proliferation to anti-CD3 mAb
over a broad dose range when compared to control Itk1
Fyn1 thymocytes (Fig. 2 A), consistent with previous stud-
ies (9, 10). Interestingly, thymocytes lacking both Itk and
Fyn exhibited a much more severe proliferative defect, de-
tectable over all doses of anti-CD3 mAb used. These results
suggest that both Fyn and Itk contribute to the proliferative
response induced by TCR stimulation in thymocytes.
Proliferation of Mature T cells in Response to anti-TCR and
Allogeneic MHC Stimulations. To examine the response of
mature peripheral T cells, splenocytes from Itk/Fyn doubly
deficient mice as well as from mice deficient in either kinase
alone or control mice were stimulated with anti-CD3 mAb
in the presence or absence of PMA. As has been previously
reported (9, 10), the proliferation of Fyn2 splenocytes was
similar to that of wild-type (Itk1Fyn1) splenocytes. On the
other hand, splenocytes lacking Itk showed a proliferative
response of 15–30% of that of the Itk1Fyn1 cells (Fig. 2 B
and data not shown). Consistent with the observation using
thymocytes, Itk2Fyn2 splenocytes had a much more pro-
found reduction in their proliferative response. Taken to-
gether, these results suggest that Itk and Fyn both make at
least some independent contributions to TCR-regulated
pathways that lead to T cell proliferative responses.
To examine the impact of these kinases on antigen-
dependent responses, mature T cells from mutant mice
were also examined in MLR. Consistent with the results
with anti-CD3 induced proliferation, Itk2Fyn2 splenocytes
responded very poorly to allogeneic MHC stimulation,
whereas  Itk-deficient splenocytes had an intermediate level
of proliferation (Fig. 3). On the other hand, splenocytes
lacking Fyn exhibited near normal alloantigen-induced
proliferation (data not shown), consistent with previous
studies (9, 10). These results support the notion that both
Figure 1. Itk/Fyn doubly deficient mice showed similar phenotypes as
Itk2 mice in T cell development. Thymocytes from 1, itk2/2, fyn2/2,
and itk2/2fyn2/2 mice were stained with antibodies against CD4, CD8,
and various other cell surface molecules, and were analyzed with flow cy-
tometry. Shown are profiles of the thymocyte subpopulations with the
percentage of total cells in each quadrant as indicated.2072 ITK and Fyn in T Cell Activation
Itk and Fyn functionally contribute to T cell responses to
alloantigens.
Discussion
We describe here the characterization of Itk/Fyn doubly
deficient mice in T cell development and activation. Our
data failed to reveal an additive effect upon thymocyte and
T cell development in mice that lack both Fyn and Itk. On
the other hand, we observed a synergistic loss of prolifera-
tive responses of these cell populations in the absence of both
Itk and Fyn. The severe defect in proliferative responses in-
duced with TCR stimulation suggests that these kinases pro-
vide at least some independent functions in the events lead-
ing to T cell and thymocyte proliferation.
Itk-deficient mice and Fyn-deficient mice have distinc-
tive phenotypes. Mice lacking Itk have a reduced ratio of
CD4 to CD8 single positive thymocytes (5). The absolute
numbers of mature CD41 T cells are also reduced by about
twofold compared to wild-type mice expressing Itk (Table
I). Fyn-deficient mice, on the other hand, do not exhibit
an obvious developmental phenotype (9, 10). The main im-
mune system defect of Fyn-deficient mice is in mature thy-
mocytes that have diminished proliferative responses as well
as reduced tyrosine phosphorylation of cellular proteins
upon TCR stimulation (9, 10). Overall, the developmental
consequences resulting from a lack of either Itk or Fyn is
quite modest.
Itk/Fyn doubly deficient mice resembled Itk-deficient mice
in their T cell developmental phenotypes, suggesting that
even in the absence of Itk, Fyn is not critically required for
T cell development, nor does it play a function that is re-
dundant with Itk. In contrast, thymocytes and mature T
cells in Itk/Fyn doubly deficient mice exhibited a severe de-
fect in proliferative responses upon TCR stimulation. This
defect was much more pronounced than would be pre-
dicted by an additive effect of lacking either kinase alone.
These data suggest that both Itk and Fyn are important in T
cells activation and are likely to play partially distinct func-
tions.
To address whether Fyn is the only specific and func-
tional partner of Itk in T cell activation, we also generated
mice deficient for both Itk and Lck, another Src family
member expressed in T cells. The developmental pheno-
types of Itk/Lck double-deficient mice resembled those of
Lck-deficient mice (data not shown; reference 8). There
was an early block of thymocyte maturation resulting in re-
duced numbers of CD41CD81 double-positive thymocytes,
Figure 3. Lack of a proliferative response with Itk2Fyn2 splenocytes in
a MLR. Splenocytes from mice of the indicated genotypes were stimu-
lated in vitro with irradiated splenocytes from C57BL/6 mice (broken
line), or from BALB/c mice (solid lines) for 96 h. Cell proliferation was
measured by [3H]thymidine incorporation after an additional 16 h. The
genotypes of mice are as indicated. Standard deviations for triplicate sam-
ples are shown as error bars along the y axis.
Figure 2. Impaired proliferative responses upon TCR stimulation of
Itk2Fyn2 thymocytes and splenocytes. (A) Thymocytes from 1, itk2/2,
fyn2/2, and itk2/2fyn2/2 mice were stimulated with anti-CD3 at indicated
concentrations in the presence of PMA (1 ng/ml) for 48 h. Cell prolifera-
tion was measured by [3H]thymidine incorporation after an additional 16 h.
The genotypes of mice are as indicated: I, itk; F, fyn. Standard deviations
for triplicate samples are shown as error bars along the y axis. (B) Spleno-
cytes from 1, itk2/2, fyn2/2, and itk2/2fyn2/2 mice were stimulated with
anti-CD3 at indicated concentrations in the presence of PMA (1 ng/ml)
for 48 h. Cell proliferation was measured by [3H]thymidine incorporation
after an additional 16 h. The genotypes of mice are as indicated in A.
Standard deviations for triplicate samples are shown as error bars along the
y axis. Data are representative of two independent experiments.2073 Liao et al. Brief Definitive Report
and very few mature T cells. Because of this early block in
development, it is difficult to assess whether Lck deficiency
exacerbates the later defect due to the absence of Itk. The
phenotype of Itk/Lck-deficient mice is also distinct from
Fyn/Lck doubly deficient mice (11, 12), which have a com-
plete lack of double-positive thymocytes. The results of Fyn/
Lck doubly deficient mice indicate that there is a certain
degree of functional redundancy between Fyn and Lck in
promoting transition of thymocytes from double-negative
to double-positive stages. The results also suggest that Lck-
deficiency provides a good platform to reveal Fyn’s contri-
bution to thymocyte development. The lack of similarity
between Itk/Lck double-deficient mice and Fyn/Lck dou-
bly deficient mice, however, suggests that Itk is not the sole
molecule mediating signals from Fyn at these specific stages
of thymocyte maturation. This interpretation is consistent
with our studies of Itk/Fyn doubly deficient mice demon-
strating that both Itk and Fyn contribute to T cell activa-
tion; lack of either kinase alone is not sufficient to abolish
T cell activation.
In B lymphocytes, Btk is thought to have functions sim-
ilar to those of Itk in T cells. Mice deficient in Btk exhibit
defects in B cell development and in BCR-mediated prolif-
erative responses. The Src-family PTK Lyn has been shown
to regulate the activity of Btk, and mice lacking Lyn have
decreased proliferative responses. In T cells, Lck and Fyn
may have functions similar to Lyn in B cells. Thus, these
PTKs may be involved in activating Itk. The finding that
the absence of Fyn exacerbates the proliferative defect of
Itk-null T cells suggests that Fyn is additionally involved in
pathways distinct from those involving Itk. At least one of
these Fyn-specific pathways may involve yet another cyto-
plasmic PTK. Recent studies have shown that in T cells, Fyn
specifically regulates TCR-mediated activation of Pyk2, a
PTK homologous to the focal adhesion kinase (14). Thus,
Fyn and Itk are likely to regulate at least some distinct events
involved in the proliferative response resulting from TCR
stimulation. Further work will be required to define these
distinct events.
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